SVRA - サバラ (Savara Inc.)

SVRAのニュース

   Stocks Volume Buzz: Savara Inc. (NASDAQ:SVRA), Solitario Zinc Corp. (AMEX:XPL)  2021/07/06 04:26:42 Stock Equity
Savara Inc. (NASDAQ:SVRA) with the stream of -3.05% also noticed, India Solitario Zinc Corp. (AMEX:XPL) encountered a rapid change of 1.75% in the last hour of Mondays trading session. Savara The post Stocks Volume Buzz: Savara Inc. (NASDAQ:SVRA), Solitario Zinc Corp. (AMEX:XPL) appeared first on Stocks Equity .
   Savara doses first patient in late-stage rare lung disease trial  2021/06/30 14:54:20 Seeking Alpha
   Savara Announces First Patient Dosed in Pivotal Phase 3 Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Trial  2021/06/30 14:47:00 Business Wire
AUSTIN, Texas--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that the first patient has been dosed in the pivotal IMPALA-2 clinical trial. IMPALA-2 is a Phase 3 trial designed to evaluate the efficacy and safety of molgramostim compared to placebo. Molgramostim is an inhaled formulation of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF). The trial is expected to be conduct
   Stock Runner: Savara Inc. (NASDAQ:SVRA), Blonder Tongue Laboratories, Inc. (AMEX:BDR)  2021/06/18 23:06:00 Stock Equity
Savara Inc. (NASDAQ:SVRA) with the stream of -1.09% also noticed, India Blonder Tongue Laboratories, Inc. (AMEX:BDR) encountered a rapid change of 0.00% in the last hour of Fridays trading session. The post Stock Runner: Savara Inc. (NASDAQ:SVRA), Blonder Tongue Laboratories, Inc. (AMEX:BDR) appeared first on Stocks Equity .
   Savara: They Failed Once, But They Are Trying Again  2021/06/07 19:03:54 Seeking Alpha
   Savara doses first patient in late-stage rare lung disease trial  2021/06/30 14:54:20 Seeking Alpha
   Savara Announces First Patient Dosed in Pivotal Phase 3 Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Trial  2021/06/30 14:47:00 Business Wire
AUSTIN, Texas--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that the first patient has been dosed in the pivotal IMPALA-2 clinical trial. IMPALA-2 is a Phase 3 trial designed to evaluate the efficacy and safety of molgramostim compared to placebo. Molgramostim is an inhaled formulation of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF). The trial is expected to be conduct
   Stock Runner: Savara Inc. (NASDAQ:SVRA), Blonder Tongue Laboratories, Inc. (AMEX:BDR)  2021/06/18 23:06:00 Stock Equity
Savara Inc. (NASDAQ:SVRA) with the stream of -1.09% also noticed, India Blonder Tongue Laboratories, Inc. (AMEX:BDR) encountered a rapid change of 0.00% in the last hour of Fridays trading session. The post Stock Runner: Savara Inc. (NASDAQ:SVRA), Blonder Tongue Laboratories, Inc. (AMEX:BDR) appeared first on Stocks Equity .
   Savara: They Failed Once, But They Are Trying Again  2021/06/07 19:03:54 Seeking Alpha
   Savara to Present at the Jefferies Virtual Healthcare Conference  2021/05/26 00:00:00 BioSpace
Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that Savara management will be presenting at the Jefferies Virtual Healthcare Conference on Wednesday, June 2, 2021 at 10:00 AM ET / 7:00 AM PT.
   Stock Runner: Savara Inc. (NASDAQ:SVRA), Blonder Tongue Laboratories, Inc. (AMEX:BDR)  2021/06/18 23:06:00 Stock Equity
Savara Inc. (NASDAQ:SVRA) with the stream of -1.09% also noticed, India Blonder Tongue Laboratories, Inc. (AMEX:BDR) encountered a rapid change of 0.00% in the last hour of Fridays trading session. The post Stock Runner: Savara Inc. (NASDAQ:SVRA), Blonder Tongue Laboratories, Inc. (AMEX:BDR) appeared first on Stocks Equity .
   Savara: They Failed Once, But They Are Trying Again  2021/06/07 19:03:54 Seeking Alpha
   Savara to Present at the Jefferies Virtual Healthcare Conference  2021/05/26 00:00:00 BioSpace
Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that Savara management will be presenting at the Jefferies Virtual Healthcare Conference on Wednesday, June 2, 2021 at 10:00 AM ET / 7:00 AM PT.
   Savara (SVRA) Received its Third Buy in a Row  2021/05/18 08:28:08 Smarter Analyst
After Piper Sandler and H.C. The post Savara (SVRA) Received its Third Buy in a Row appeared first on Smarter Analyst .
   Caxton Corp Buys Savara Inc, Kala Pharmaceuticals Inc, Ares Acquisition Corp, Sells XL Fleet ...  2021/05/17 17:38:29 GuruFocus
Related Stocks: KALA , FB , MA , WHR , SPGI , V , SVRA , AAC.U , AJAX , MRAC , ONCS , SR ,

calendar